Company news

Ipsen SA news in 2025

Ipsen SA's news releases, calls and decks from 2025, newest first.

View company

Late-breaking exploratory data highlights the impact of IQIRVO® (elafibranor) on fatigue and provides mechanistic insights into anti-inflammatory and symptom-related effects in patients with primary biliary cholangitis

May 7, 2025

Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation

May 6, 2025

Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting

April 30, 2025

← Newer news releases

Calls in 2025

Decks in 2025